Neurocrine Bioscience buy Guggenheim
Start price
21.07.26
/
50%
€157.15
Target price
21.07.27
€175.28
Performance (%)
-15.24%
Price
19.08.26
€133.20
Summary
This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -15.24%. This prediction currently runs until 21.07.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -1.951% |
| iShares Core DAX® | -1.059% |
| iShares Nasdaq 100 | -2.387% |
| iShares Nikkei 225® | -4.361% |
| iShares S&P 500 | -1.778% |
Comments by Guggenheim for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Guggenheim from $175.00 to $200.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Guggenheim for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€144.40
31.07.26
31.07.26
€192.87
31.07.27
31.07.27
-7.76%
19.08.26
19.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.15
06.05.26
06.05.26
€149.31
06.05.27
06.05.27
8.16%
19.08.26
19.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.15
06.05.25
06.05.25
€146.09
06.05.26
06.05.26
14.56%
07.05.26
07.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€120.00
10.02.25
10.02.25
€157.98
10.02.26
10.02.26
-2.54%
11.02.26
11.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€140.30
02.08.24
02.08.24
€164.90
02.08.25
02.08.25
-21.03%
03.08.25
03.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€158.42
02.05.25
02.05.25
-26.05%
03.05.25
03.05.25